Red Cell Special Interest Group
Day: Wednesday | Time: 15:00 - 16:30 | Room: 1
Available Presentations
Erythrocyte mediated enzyme replacement therapy
Briget Bax
Joint narrative of RBC storage lesion: The use of advanced technologies for better understanding of variability associated with donor, process, storage media/ time and recipient issues
Jerard Seghatchian
Extrusion of autophagic vesicles by human reticulocytes explains phosphatidylserine-positive red cells in sickle cell disease
Tosti Mankelow
Session Coordinators: Lesley Bruce, Kay Ridgwell
Speakers:
Dr Briget Bax
Institute of Cardiovascular and Cell Sciences, St George’s, University of London
Dr Jerard Seghatchian
International Consultancy in Blood component Quality/ Safety Improvement & DDR Strategies, London
Dr Tosti Mankelow
Bristol Institute for Transfusion Sciences, NHSBT, Bristol
Intended Audience:
Biomedical Scientists and trainees working in hospital transfusion departments, UK Blood Services, and associated services.
Research scientists involved in basic research work.
Clinicians who prescribe blood components in haematology, surgery, intensive care, obstetrics and trauma settings.
Transfusion practitioners.
Learning Objectives:
Red cells release vesicles during reticulocyte maturation, in order to prolong the life of mature erythrocytes, and during storage. Learn how these vesicles can be both harmful and beneficial. Plus learn about how both vesicles and red cells are being developed to deliver and target drugs to diseased tissues.
Brief Description:
Erythrocyte mediated enzyme replacement therapy
Briget Bax
Jerard Seghatchian
Tosti Mankelow
Session Tags:
